Klatzmann D, Gluckman J C, Chapuis F, Foucault C
Transplantation. 1984 Sep;38(3):222-6. doi: 10.1097/00007890-198409000-00005.
It has previously been demonstrated that blood transfusions (BT) can induce the generation of suppressor cells in the mixed lymphocyte reaction (MLR). We have further investigated whether regulation of the alloimmune response could also be observed at the cell-mediated lympholysis (CML) level. We have, therefore, prospectively analyzed the effect of the first 2 BT on cytotoxic T lymphocyte (CTL) differentiation in previously nontransfused uremic patients. Different patterns of CML changes were noted. In 7 cases, marked CML reduction was observed after the first BT, and in 7 others CML remained unchanged or even increased after the first BT, but reduced CML occurred after the second. Increased CML was noted in the last 4 cases. When present, reduction in CML after BT could indeed occur upon in vitro restimulation by cells of the specific donor, but also by those of other individuals regardless whether they shared HLA antigens. Post-BT lymphocytes the CML of which was decreased could inhibit CML of autologous pre-BT cells when used as an irradiated third-party at the initiation of the sensitization step. No correlation, however, was generally observed between MLR and CML suppressions when both were tested in parallel assays. CML reduction could occur in the presence of unchanged or increased MLR, and no cytotoxicity to the stimulating cells could be observed in direct cytolysis assays, so this inhibition can be attributed to suppressor cells of CTL differentiation that are generated in vivo after BT in man.
先前已经证明输血(BT)可在混合淋巴细胞反应(MLR)中诱导抑制细胞的产生。我们进一步研究了在细胞介导的淋巴细胞溶解(CML)水平上是否也能观察到同种免疫反应的调节。因此,我们前瞻性地分析了前两次输血对先前未输血的尿毒症患者细胞毒性T淋巴细胞(CTL)分化的影响。观察到CML有不同的变化模式。7例患者在首次输血后CML明显降低,另外7例患者在首次输血后CML保持不变甚至升高,但在第二次输血后CML降低。最后4例患者CML升高。当出现输血后CML降低时,在体外经特定供体的细胞再刺激后确实会发生,而且经其他个体的细胞再刺激也会发生,无论这些个体是否共享HLA抗原。输血后CML降低的淋巴细胞在致敏步骤开始时用作照射的第三方时,可抑制自体输血前细胞的CML。然而,当在平行试验中同时检测MLR和CML抑制时,通常未观察到两者之间的相关性。在MLR不变或升高的情况下,CML可能降低,并且在直接细胞溶解试验中未观察到对刺激细胞的细胞毒性,因此这种抑制可归因于人体输血后体内产生的CTL分化抑制细胞。